Valuation
Live · Yahoo FinancePrice
$444.00
52-Week Range
4-engine score — Quality and Peers engines require SEC EDGAR (US stocks only)
Based on filing period ending Jun 2026
International FisclearScore uses 4 engines (no EDGAR data). Based on Yahoo Finance & Alpha Vantage reported financials. Not financial advice.
SWOT Analysis — SOBI.ST
Inflationary BoomStrengths
No standout strengths identified from the filing.
Weaknesses
Stock is near its 52-week high (451.80) — the price reflects strong recent momentum, but entry risk is elevated at these levels.
Opportunities
No clear opportunities identified at this time.
Threats
No significant threats flagged.
Risk Flags
0 high · 0 medium · 1 low- ○ Low
Stock is near its 52-week high (451.80) — the price reflects strong recent momentum, but entry risk is elevated at these levels.
Price HistorySEK
Technical Signals
Daily closes · 1-year dataLatest News
via FinnhubFiling History — SOBI.ST
Get the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Research Swedish Orphan Biovitrum AB (publ)
Data sourced from Nasdaq Stockholm, FRED (Federal Reserve), OECD, BIS, and Yahoo Finance. For informational purposes only. Not financial advice.